\n| \n (in millions, except per share data)<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended
\n
<\/b>Dec. 31, 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended
\n
<\/b>Dec. 31, 2023<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRevenue<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n307.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n341.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nOperating earnings (loss)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(53.6<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted operating earnings*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n24.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted EBITDA*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n32.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n62.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet loss<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(23.6<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(75.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet loss per diluted share<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.57<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(1.83<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(22.9<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings*<\/sup> per diluted share<\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.55<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.07<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n*Non-GAAP financial measure. Reconciliations to the most directly comparable GAAP financial measure are provided in tables at the end of this press release.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n SALT BUSINESS COMMENTARY<\/span><\/b><\/p>\n\nReducing North American highway deicing salt inventory volumes has been a focus for Compass Minerals, which led to the company’s decision to curtail production at Goderich mine and to a lesser extent Cote Blanche mine in 2024. The company is gaining traction on this initiative with North American highway deicing inventory volumes down 10% year over year despite a delayed start to the winter deicing season. The curtailment of production at Goderich mine resulted in higher cost production per ton, due to lower fixed cost absorption, being inventoried throughout 2024. As the company begins to sell this higher cost 2024 inventory, there is an impact to cost per ton that is reflected in the results below. Compass Minerals’ view is the benefits to the company from reducing excess inventory, including harvesting working capital tied up inventory and contributing to a rebalancing of supply across the market, outweigh the transient production cost per ton impacts from curtailing production.<\/p>\n \nWinter weather was late in arriving in the first quarter, with minimal snow event activity occurring in the company’s served markets in October and November. With customer inventories full following last year’s exceptionally mild deicing season, the slow start to winter weather resulted in lower sales volumes during the first quarter of fiscal 2025 compared to prior year.<\/p>\n \nThe factors above contributed to operating earnings declining 42% year over year to $29.4 million and adjusted EBITDA decreasing to $47.8 million, down 28% from the prior-year period. Adjusted EBITDA per ton declined 17% to $19.17.<\/p>\n \nSalt revenue totaled $242.2 million and was down 12% year over year, driven by a 13% year-over-year sales volume decline, partially offset by a 1% increase in average sales price. In the highway deicing business, the company’s disciplined approach to pricing throughout the 2025 deicing bid season resulted in only a 1% decrease in average highway deicing selling price despite high inventory levels across the broader market following two mild winters, including one of the mildest winters in the company’s served markets in nearly a quarter century. Sales volumes declined 12% due to a combination of low pre-fill activity and mild weather in October and November. Consumer and industrial (C&I) pricing rose 6% year over year to approximately $206 per ton, while sales volumes declined by 14%, primarily due to lower retail deicing demand reflecting the aforementioned mild weather across the company’s served markets.<\/p>\n \nDistribution costs per ton decreased 2% year over year, while all-in product costs (defined at the segment level as sales to external customers less distribution costs less operating earnings) per ton rose 16% from the comparable prior-year quarter due to the production cost dynamics for 2024-produced salt described above.<\/p>\n PLANT NUTRITION BUSINESS COMMENTARY<\/span><\/b><\/p>\n\nIn Plant Nutrition, the company has been working predominantly on improving the cost structure of the segment. In particular, the ongoing restoration of the pond complex at Ogden is expected to allow for an improvement in the consistency and grade of sulfate of potash (SOP) raw materials going to the plant. Recent results from our pond restoration activities suggest that these initiatives are having a positive impact on the ponds, which is a critical step in improving the Plant Nutrition business. Additional opportunities to improve productivity and increase process efficiencies are also being evaluated and pursued. Results from these actions are beginning to take effect, which is reflected in the quarterly results below.<\/p>\n \nPlant Nutrition revenue for the quarter totaled $61.4 million, up 24% year over year on strong sales volume. This was led by improved sales volumes, which grew by 27 thousand tons, a 36% improvement year over year. The average segment sales price for the quarter was down 9% year over year to approximately $603 per ton, reflecting supply conditions of potassium-based fertilizers globally. Per-unit distribution costs for the quarter decreased 2% year over year, largely due to increased sales rates absorbing fixed rail transport costs. All-in product costs per ton decreased 10% year over year.<\/p>\n \nOperating loss per ton in the Plant Nutrition business improved by 1% year over year. This, combined with the increase in sales volumes between periods, resulted in a slight increase in operating loss to $3.1 million for the quarter, compared to operating loss of $2.3 million in the prior-year quarter. Absolute adjusted EBITDA declined to $4.4 million versus $7.2 million last year due to a decline in per-unit adjusted EBITDA attributable to a decrease in DD&A per sales ton.<\/p>\n FORTRESS NORTH AMERICA COMMENTARY<\/span><\/b><\/p>\n\nCompass Minerals continues to evaluate various alternatives regarding the path forward for Fortress North America (Fortress). Discussions are ongoing with the U.S. Forest Service (USFS) regarding the evaluation and testing of the company’s conditionally qualified technical grade orthophosphate-based aerial fire retardant, Qela.<\/p>\n CASH FLOW AND FINANCIAL POSITION<\/span><\/b><\/p>\n\nNet cash used in operating activities amounted to $4.1 million for the three months ended Dec. 31, 2024, compared to $52.3 million in the prior year. Despite a weaker start to the winter deicing season, reduction to inventory levels contributed to an improvement in working capital year over year.<\/p>\n \nNet cash used in investing activities was $22.2 million for the three months ended Dec. 31, 2024, down $27.1 million year over year principally driven by lower capital spending. Total capital spending for the three months ended Dec. 31, 2024 was $21.8 million.<\/p>\n \nNet cash provided by financing activities was $53.1 million for the three months ended Dec. 31, 2024, which included net borrowings of $57.5 million. In the prior year, net cash provided by financing activities reflected net borrowings of $108.1 million.<\/p>\n \nThe company ended the quarter with $126.3 million of liquidity, comprised of $45.8 million in cash and cash equivalents and $80.5 million of availability under its $325 million revolving credit facility.<\/p>\n UPDATED FISCAL 2025 OUTLOOK<\/span><\/b><\/p>\n\nGiven the quickly evolving dynamics surrounding potential tariffs on products imported to the United States from the company’s Canadian operations, the company has not included any potential impacts related to tariffs into the guidance below. For fiscal 2025, any impact to adjusted EBITDA is expected to be negligible for the North American highway deicing business as salt for the 2024\/2025 season has already been imported and deployed across the company’s depot network. Compass Minerals is evaluating the potential impact to the C&I and Plant Nutrition businesses resulting from any potential tariff actions.<\/p>\n \n\n| \n Salt Segment<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range1<\/sup><\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nHighway deicing sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n7,600 – 8,500<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nConsumer and industrial sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n1,800 – 1,950<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal salt sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n9,400 – 10,450<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRevenue (in millions)<\/i><\/p>\n<\/td>\n | \n \n$900 – $1,000<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$205 – $230<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nRange for fiscal 2025 reflects the company’s committed book of business for the period and assumes an average historical sales-to-commitment outcomes.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nAs described above, mild winter weather for the first two months of the quarter contributed to a softer quarter than had been assumed in the company’s original forecast. January saw strong winter weather across portions of the company’s served markets and preliminary results for the month suggest the company may be able to partially offset the weather-driven shortfall from the first quarter.<\/p>\n \n\n| \n Plant Nutrition Segment<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nSales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n295 – 315<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRevenue (in millions)<\/i><\/p>\n<\/td>\n | \n \n$180 – $200<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$17 – $24<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nPlant Nutrition guidance is being increased to reflect revised market and operational conditions and assumptions that could impact the business, with expected pressure in global potash pricing being more than offset by higher sales expectations and lower forecasted production costs for the year.<\/p>\n \n\n| \n Corporate<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Total1<\/sup><\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n($70) – ($61)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nIncludes $3 to $5 million in cash expenses related to Fortress.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nProjected Corporate segment results in the table above, which are unchanged from the company’s initial guidance provided in December of 2024, include corporate expenses in support of the company’s core businesses, Fortress financial results, and the results of DeepStore, the company’s records and management services business in the U.K.<\/p>\n \n\n| \n Total Compass Minerals<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Adjusted EBITDA<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Salt<\/b><\/p>\n<\/td>\n | \n Plant Nutrition<\/b><\/p>\n<\/td>\n | \n Corporate1<\/sup><\/b><\/p>\n<\/td>\n| \n Total<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$205 – $230<\/p>\n<\/td>\n | \n \n$17 – $24<\/p>\n<\/td>\n | \n \n($70) – ($61)<\/p>\n<\/td>\n | \n \n$152 – $193<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Capital Expenditures<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Total<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nCapital expenditures (in millions<\/i>)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$75 – $85<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nIncludes financial contribution from DeepStore and Fortress.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nTotal planned capital expenditures for the company in fiscal 2025 have been reduced and are now expected to be within a range of $75 million to $85 million, down from a range of $100 million to $110 million provided in the company’s original guidance. The company is committed to managing capital expenditures so that they align with the cash generation performance of the business.<\/p>\n \n\n| \n Other Assumptions<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n ($ in millions)<\/i><\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nDepreciation, depletion and amortization<\/p>\n<\/td>\n | \n \n$105 – $115<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nInterest expense, net<\/p>\n<\/td>\n | \n \n$67 – $72<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nEffective income tax rate (excl. valuation allowance)<\/p>\n<\/td>\n | \n \n0% – 5%<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nGuidance for the 2025 effective income tax rate reflects the income mix by country with income recognized in foreign jurisdictions offset by losses recognized in the U.S.<\/p>\n CONFERENCE CALL<\/span><\/b><\/p>\n\nCompass Minerals will discuss its results on a conference call tomorrow morning, Tuesday, Feb. 11, at 9:30 a.m. ET (8:30 a.m. CT). To access the conference call, please visit the company\u2019s website at investors.compassminerals.com or dial 800-715-9871. Callers must provide the conference ID number 7896827. Outside of the U.S. and Canada, callers may dial 646-307-1963. Replays of the call will be available on the company\u2019s website.<\/p>\n \nA supporting corporate presentation with 2025 first-quarter results is available at investors.compassminerals.com.<\/p>\n About Compass Minerals<\/b><\/p>\n \nCompass Minerals (NYSE: CMP) is a leading global provider of essential minerals focused on safely delivering where and when it matters to help solve nature\u2019s challenges for customers and communities. The company\u2019s salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial, chemical and agricultural applications. Its plant nutrition products help improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, it is working to develop a long-term fire-retardant business. Compass Minerals operates 12 production and packaging facilities with nearly 1,900 employees throughout the U.S., Canada and the U.K. Visit compassminerals.com<\/a> for more information about the company and its products.<\/p>\nForward-Looking Statements and Other Disclaimers<\/span><\/b><\/p>\nThis press release may contain forward-looking statements, including, without limitation, statements about reduction of salt inventory volumes, improvement in Plant Nutrition costs, cash generation capability, the future of Fortress, including ongoing discussions with the USFS, the company’s ability to meet or exceed its plan for January or the remainder of fiscal 2025, SOP prices, and the company’s outlook for 2025, including its expectations regarding sales volumes, revenue, Adjusted EBITDA, depreciation, depletion, and amortization, interest expense, tax rates, and capital expenditures. Forward-looking statements are those that predict or describe future events or trends and that do not relate solely to historical matters. The company uses words such as \u201cmay,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201clikely,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cproject,\u201d \u201cestimate\u201d and similar expressions suggesting future outcomes or events to identify forward-looking statements or forward-looking information. These statements are based on the company\u2019s current expectations and involve risks and uncertainties that could cause the company\u2019s actual results to differ materially. The differences could be caused by a number of factors, including without limitation (i) weather conditions, (ii) inflation, the cost and availability of transportation for the distribution of the company\u2019s products and foreign exchange rates, (iii) pressure on prices and impact from competitive products, (iv) any inability by the company to successfully implement its strategic priorities or its cost-saving or enterprise optimization initiatives, and (v) the risk that the company may not realize the expected financial or other benefits from its ownership of Fortress North America. For further information on these and other risks and uncertainties that may affect the company\u2019s business, see the \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d sections of the company\u2019s Amended Annual Report on Form 10-K for the period ended Sept. 30, 2024, and its Quarterly Report on Form 10-Q for the quarter ended Dec. 31, 2024, filed or to be filed with the SEC, as well as the company’s other SEC filings. The company undertakes no obligation to update any forward-looking statements made in this press release to reflect future events or developments, except as required by law. Because it is not possible to predict or identify all such factors, this list cannot be considered a complete set of all potential risks or uncertainties.<\/i><\/p>\n Non-GAAP Measures<\/b><\/p>\n In addition to using U.S. generally accepted accounting principles (\u201cGAAP\u201d) financial measures, management uses a variety of non-GAAP financial measures described below to evaluate the company\u2019s and its operating segments\u2019 performance. While the consolidated financial statements provide an understanding of the company\u2019s overall results of operations, financial condition and cash flows, management analyzes components of the consolidated financial statements to identify certain trends and evaluate specific performance areas.<\/i><\/p>\n Management uses EBITDA, EBITDA adjusted for items which management believes are not indicative of the company\u2019s ongoing operating performance (\u201cAdjusted EBITDA\u201d) and EBITDA margin to evaluate the operating performance of the company\u2019s core business operations because its resource allocation, financing methods and cost of capital, and income tax positions are managed at a corporate level, apart from the activities of the operating segments, and the operating facilities are located in different taxing jurisdictions, which can cause considerable variation in net earnings. Management also uses adjusted operating earnings, adjusted operating margin, adjusted net earnings, and adjusted net earnings per diluted share, which eliminate the impact of certain items that management does not consider indicative of underlying operating performance. The presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or non-recurring items. Management believes these non-GAAP financial measures provide management and investors with additional information that is helpful when evaluating underlying performance. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation, depletion and amortization, each of which are an essential element of the company\u2019s cost structure and cannot be eliminated. In addition, Adjusted EBITDA and Adjusted EBITDA margin exclude certain cash and non-cash items, including stock-based compensation, impairment charges and certain restructuring charges. Consequently, any measure that excludes these elements has material limitations. The non-GAAP financial measures used by management should not be considered in isolation or as a substitute for net earnings, operating earnings, cash flows or other financial data prepared in accordance with GAAP or as a measure of overall profitability or liquidity. These measures are not necessarily comparable to similarly titled measures of other companies due to potential inconsistencies in the method of calculation. The calculation of non-GAAP financial measures as used by management is set forth in the following tables. All margin numbers are defined as the relevant measure divided by sales. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring, unusual items and\/or distinct non-core initiatives without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company\u2019s results.<\/i><\/p>\n Adjusted operating earnings, adjusted operating earnings margin, adjusted net earnings (loss), and adjusted net earnings (loss) per diluted share are presented as supplemental measures of the company\u2019s performance. Management believes these measures provide management and investors with additional information that is helpful when evaluating underlying performance and comparing results on a year-over-year normalized basis. These measures eliminate the impact of certain items that management does not consider indicative of underlying operating performance. These adjustments are itemized below. Adjusted net earnings (loss) per diluted share is adjusted net earnings (loss) divided by weighted average diluted shares outstanding. You are encouraged to evaluate the adjustments itemized above and the reasons management considers them appropriate for supplemental analysis. In evaluating these measures you should be aware that in the future the company may incur expenses that are the same as or similar to some of the adjustments presented below.<\/i><\/p>\n\n\n| \n Special Items Impacting the Three Months Ended Dec. 31, 2024<\/b><\/p>\n \n(unaudited, in millions, except per share data)<\/p>\n<\/td>\n<\/tr>\n | \n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nProduct recall costs<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nSalt<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nProduct cost and Other operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.02<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.02<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Special Items Impacting the Three Months Ended Dec. 31, 2023<\/b><\/p>\n \n(unaudited, in millions, except per share data)<\/p>\n<\/td>\n<\/tr>\n | \n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n2.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n2.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.06<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nPlant Nutrition<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.02<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nImpairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nLoss on impairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n74.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n74.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.82<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n78.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n78.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n1.90<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nThere were no substantial income tax benefits related to these items given the U.S. valuation allowances on deferred tax assets. Applicable product recall costs reflect an impact from Canadian taxes.<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n(2)<\/p>\n<\/td>\n | | \n\n \nRestructuring charges do not include certain reductions in stock-based compensation associated with forfeitures stemming from the restructuring activities.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Reconciliation for Adjusted Operating Earnings<\/b><\/p>\n \n(unaudited, in millions)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended
\n
<\/b>Dec. 31,<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2023<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nOperating earnings (loss)<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(53.6<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nProduct recall costs(1)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nLoss on impairments(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n74.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted operating earnings<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n1.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n24.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nSales<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n307.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n341.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nOperating margin<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.2<\/p>\n<\/td>\n | \n \n%<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(15.7<\/p>\n<\/td>\n | \n \n)%<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted operating margin<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.5<\/p>\n<\/td>\n | \n \n%<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n7.3<\/p>\n<\/td>\n | \n \n%<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nThe company recognized costs related to a recall related to food-grade salt produced at its Goderich Plant.<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n(2)<\/p>\n<\/td>\n | | \n\n \nIn connection with the termination of the company’s lithium development project, the company incurred severance and related charges for a reduction in workforce and a loss on impairment of long-lived assets, which were determined to be no longer probable of recovery.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Reconciliation for Adjusted Net (Loss) Earnings<\/b><\/p>\n \n(unaudited, in millions)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended
\n
<\/b>Dec. 31,<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2023<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nNet loss<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(23.6<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(75.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nProduct recall costs(1)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nLoss on impairments(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n74.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nIncome tax effect<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(22.9<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n3.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet loss per diluted share<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.57<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(1.83<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings per diluted share<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.55<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.07<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nWeighted-average common shares outstanding (in thousands):<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nDiluted<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n41,441<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n41,205<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | | \n\n \nThe company recognized costs related to a recall related to food-grade salt produced at its Goderich Plant. Charges for the three months ended Dec. 31, 2024 were $0.9 million ($0.7 million net of tax).<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n(2)<\/p>\n<\/td>\n | | \n\n \nIn connection with the termination of the company’s lithium development project, the company incurred severance and related charges for a reduction in workforce and a loss on impairment of long-lived assets, which were determined to be no longer probable of recovery.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Reconciliation for EBITDA and Adjusted EBITDA<\/b><\/p>\n (unaudited, in millions)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended<\/b><\/p>\n Dec. 31,<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2023<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet loss<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(23.6<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(75.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nInterest expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n16.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n15.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nIncome tax expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n9.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nDepreciation, depletion and amortization<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n26.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n25.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nEBITDA<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n29.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(30.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjustments to EBITDA:<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nStock-based compensation – non-cash<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n11.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nInterest income<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.4<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.4<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n(Gain) loss on foreign exchange<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(5.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nProduct recall costs(1)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.9<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nLoss on impairments(2)<\/sup><\/p>\n<\/td>\n| \n | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |